The phenomenon of topical steroid withdrawal (TSW) is gaining attention as an increasing number of individuals report debilitating symptoms following the long-term use of steroid creams. This condition, often dismissed by healthcare professionals, has prompted a wave of advocacy and research aimed at uncovering its true nature and impact on patients.
The Personal Stories Behind TSW
Bethany Gamble, a 21-year-old from Birmingham, has experienced the harsh realities of TSW first-hand. From the age of two, she relied on steroid creams to manage her eczema, a chronic condition that was once manageable. However, by 18, her symptoms escalated dramatically. “My skin was hot, so inflamed and red. It began to crack and ooze, and the itch was bone deep. It consumed my whole body, and then it began to consume my whole life,” she recalls. By the age of 20, her condition had deteriorated to the point where she was bedridden, reliant on her mother for care, and struggling to convince doctors of the severity of her situation.
Bethany’s experiences are not unique; she is part of a growing community on social media that shares similar struggles using the hashtag TSW, which has garnered over a billion views on TikTok. This online movement highlights a condition that remains under-researched and misunderstood by many healthcare professionals.
A Lack of Consensus Among Experts
Topical steroid withdrawal, sometimes referred to as red skin syndrome, remains contentious within the medical community. Some experts attribute it to a severe reaction to topical steroids, while others view it as an exacerbation of eczema or an entirely separate condition. The variability in symptoms—ranging from intense redness to skin peeling—complicates diagnosis and treatment, leaving many patients feeling neglected and frustrated.
Professor Sara Brown, a consultant dermatologist at the University of Edinburgh, has begun to investigate TSW after noticing alarming patterns in her patients’ symptoms. “We’re seeing patterns in TSW that cannot be explained by what is known about eczema,” she states. In collaboration with Dr Alice Burleigh from the patient advocacy group Scratch That, Professor Brown has begun a significant study designed to explore the underlying mechanisms of TSW, recruiting hundreds of participants across the UK to analyse their symptoms and biological samples.
The Experiences of Those Affected
Henry Jones, a 22-year-old from High Wycombe, describes his journey as a “TSW warrior.” Initially using steroids to manage his eczema, he soon found that his symptoms intensified, leading to a complete disruption of his life. “My GP at university kept telling me it was just eczema—and kept prescribing me more steroid cream. Something didn’t feel right,” he explains. As his skin deteriorated, he experienced severe pain and isolation, forced to abandon his studies while grappling with thoughts of despair.
Similarly, Karishma Leckraz from Kent faced the challenge of recognising her symptoms, which manifested differently on her skin, making it difficult to relate to the experiences shared by others online. After years of denial, she ceased using steroid creams five years ago and has since worked to manage her recovery, though she continues to contend with significant mental health implications.
The Need for Greater Understanding and Support
The National Eczema Society’s representative, Andrew Procter, underscores the challenging position many patients find themselves in. “We know that steroids work for the many millions who use them. But we also have a condition that at the moment can’t be explained, which is causing real fear—and that is completely understandable,” he says. With long waiting times for dermatology appointments, many patients are left feeling trapped in a cycle of inadequate treatment options.
Dr Alia Ahmed, a consultant dermatologist at the Royal London Hospital, offers specialised care for chronic skin diseases, including psychological support and alternative therapies. “The psychological impact, as well as the physical effects, is huge,” she notes, emphasising the need for a patient-centred approach to treatment.
In 2021, the Medicines and Health Regulatory Authority (MHRA) officially recognised TSW as a severe reaction to steroid creams. Despite this, the condition is still considered relatively rare, causing confusion and fear among patients seeking help. The Royal College of GPs acknowledges the effectiveness of steroid creams but advises caution regarding their long-term use.
As individuals like Rebecca Ebbage, who turned to private treatment after a year-long wait for specialist care, navigate their healing journeys, the push for more research and awareness continues to grow. Rebecca highlights the pervasive nature of her condition, stating, “My skin governs what I am allowed to do, what I can eat and even what I can wear.”
Why it Matters
The ongoing struggles of those affected by TSW illuminate a significant gap in our understanding of steroid treatments and their potential repercussions. As social media platforms amplify these personal narratives, they not only serve as a source of solidarity for individuals suffering in silence but also highlight the urgent need for comprehensive research and education within the medical community. Addressing the complexities of TSW could transform lives and foster a more informed approach to managing eczema and similar skin conditions, ultimately ensuring better health outcomes for millions.
